Table 2

Comparison of infants with and without necrotising enterocolitis

Clinical featuresWith NEC (n=28)Without NEC (n=112)
Gestational age (weeks)28.1 (26.3 to 30.4)29.0 (27.7 to 30.9)
Birthweight (g)1095 (873 to 1348)1195 (960 to 1330)
Sex (female:male)14 (50):14 (50)50 (45):62 (55)
Inborn:outborn26 (93):2 (7)109 (97):3 (3)
Antenatal corticosteroid treatment17 (61)78 (70)
Mode of delivery
 Vaginal18 (64)43 (38)
 Caesarean section10 (36)66 (59)
 Ventouse0 (0)2 (2)
 Forceps0 (0)1 (1)
Apgar scores
 1 min < 35 (18)14 (13)
 5 min < 31 (4)1 (1)
First arterial blood gas after delivery
 pH7.37 (7.32 to 7.45)7.36 (7.30 to 7.44)
 Base excess−2.4 (−5.0 to −0.80)−2.6 (−5.6 to −0.9)
Temperature on admission (°C)36.0 (35.8 to 36.8)36.2 (35.6 to 36.6)
First venous haematocrit after delivery0.52 (0.47 to 0.55)0.51 (0.45 to 0.57)
Lowest mean arterial blood pressure (mm Hg)27.5 (22.5 to 31.5)27 (22 to 32)
Exchange transfusion1 (4)1 (1)
Umbilical arterial catheterisation18 (64)62 (55)
Umbilical venous catheterisation24 (86)90 (80)
Aminophylline treatment20 (71)57 (51)
Respiratory distress syndrome
 Stage 0-220 (71)86 (77)
 Stage 3-48 (29)26 (23)
Periventricular haemorrhage
 Stage < 226 (93)94 (84)
 Stage 3-42 (7)18 (16)
Patent ductus arteriosus
 Indomethacin closure15 (54)57 (51)
 Surgical ligation2 (7)3 (3)
Age started on enteral feeds (days)6.5 (4 to 14.5)6 (4 to 9)
Age received full enteral feeds (days) 36 (23 to 61)26 (19 to 37)
Type of milk feeds
 Breast3 (11)17 (15)
 Formula11 (39)50 (45)
 Mixed14 (50)45 (40)
Stool culture (fungus: Gram (−): Gram (+))
 Before prophylaxis0 (0):0 (0):5 (18)3 (3):8 (7):20 (18)
 Immediately after prophylaxis4 (14):6 (21):0 (0)13 (12):16 (14):3 (3)
 Four weeks after prophylaxis2 (7):6 (21):1 (4)3 (3):24 (21):1 (1)
Duration of mechanical ventilation (days)9.5 (2 to 31)6.5 (3 to 16)
Duration of O2 dependency (days)16 (3.5 to 47.5)10 (3 to 34)
Duration of hospital stay (days)2-150 115 (90 to 144)81 (55 to 110)
Died2-150 9 (32)15 (13)
  • Continuous variables are expressed in median (interquartile ranges) and proportions in number of patients (%).

  • 2-150 p<0.05.